Short Wave Pharma
Psilocybin-based Products for Treatment of Mental Health Disorders
StartupShort Wave Pharma is a Ramat HaSharon-based startup in the Health Tech & Life Sciences sector, established in 2021. Psilocybin-based Products for Treatment of Mental Health Disorders. Short Wave Pharma was founded by Rivki Stern Youdkevich and Nadya Lisovoder. The company has 1-10 employees. Core technologies: Biologicals.
The company follows a B2C/B2B/B2G business model. Product stage: Clinical Trial.
- StagePre-Funding
- ProductClinical Trial
- ModelB2C, B2B, B2G
- Employees1-10
- HQRamat HaSharon
- Last RoundUndisclosed
Rivki Stern YoudkevichCo-founder & CEO
Nadya LisovoderCo-founder & CRO
1 article covered by sources including www.calcalistech.com.
What does Short Wave Pharma do?
Short Wave Pharma is a biopharmaceutical company developing novel formulations of psilocybin and additional APIs, along with customized delivery methods, for patients living with mental health disorders, neurodegenerative diseases, chronic pain, and any other medical conditions for which psilocybin is known to have a positive effect. Short Wave Pharma has begun preclinical studies related to its product for anorexia nervosa. The company’s future programs include the development of novel formulations and delivery approaches for chronic pain and neurodegenerative diseases.
Who founded Short Wave Pharma?
Short Wave Pharma was founded in 2021 by Rivki Stern Youdkevich (Co-founder & CEO), Nadya Lisovoder (Co-founder & CRO).
What sector is Short Wave Pharma in?
Short Wave Pharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Drug Delivery, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Short Wave Pharma located?
Short Wave Pharma is based in Sderot Bialik 39, Ramat HaSharon, Israel. The company also has offices abroad.